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The discovery of broad and potent HIV-1 neutralizing antibodies (bNAbs) has renewed 
optimism for developing an effective vaccine against HIV-1. The generation of most 
bNAbs requires multiple rounds of B cell receptor affinity maturation, suggesting a 
crucial role of follicular helper T (Tfh) cells in their production. However, less than 1% 
of HIV-infected patients develop bNAbs that arise late in the course of infection, indi-
cating probable Tfh and B cell dysfunctions in this context. Since the last few years, 
many studies have characterized Tfh cells from lymph nodes and spleen of HIV-infected 
individuals and SIV-infected macaques. Various lymphoid Tfh cell subsets have been 
identified, including precursor Tfh (pTfh), germinal center Tfh (GC Tfh), and the regulatory 
counterpart of Tfh cells, the follicular regulatory T cells. The latter have been reported 
to play a crucial role in the control of T and B cell crosstalk and GC reactions. More 
recently, circulating Tfh-like cells (cTfh) have been identified. Meanwhile, advances in 
single-cell technologies have made possible to analyze the transcriptional profiles of low 
abundant cells, such as Tfh populations. Using transcriptional signatures, we review here 
the impact of chronic SIV/HIV infection on Tfh, GC Tfh, pTfh, and cTfh differentiation and 
helper T cell functions with regard to their capacity to induce efficient B cell maturation. 
We will explore some hypothesis to explain the increased proportion of Tfh cells reported 
in chronically infected individuals and the impact on HIV pathogenesis.
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iNTRODUCTiON
In germinal centers (GC), T follicular helper (Tfh) cells deliver helper signals and cytokines required 
for B cell affinity maturation and B cell differentiation into long-lived plasma cells. Optimal Tfh and 
B cell crosstalk is a prerequisite for the induction of efficient humoral immunity to pathogens. By 
providing survival and differentiation signals, Tfh cells control multiple steps of B cell maturation 
and antibody (Ab) production.
In addition to the cognate antigen interaction with B cells, Tfh cells express costimulatory 
molecules, such as CD40L, ICOS, and OX40. Tfh cells secrete high levels of interleukin-21 (IL-21) 
and IL-4, which are necessary for GC formation and B cell differentiation into long-lived plasma 
cells, respectively (1–3).
Among tissue-resident Tfh cell subsets, early committed precursor Tfh (pTfh) and germinal 
center Tfh (GC Tfh) represent two different stages of the Tfh cell maturation. Follicular regulatory 
FiGURe 1 | impact of Hiv antigen persistence on Tfh cell differentiation in lymphoid tissues. Linear and alternative post-effector Tfh cell differentiation 
pathways are described. (1) Interactions between HIV particles and DC-SIGN expressing DCs could support the T helper cell differentiation toward a Tfh 
polarization. (2) According to the alternative post-effector differentiation pathway, HIV persistence might support Th1 and memory T cell differentiation into Tfh cells.
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T (Tfr) cells are identified as the regulatory counterpart of Tfh 
cells. Tfr cells control T and B cell crosstalk and GC reactions. 
Blood circulating Tfh cells (cTfhs) have been recently identified as 
a memory compartment of tissue-resident Tfh cells. Like tissue-
resident Tfh cells, cTfhs are endowed with the capacity to produce 
IL-21 and to provide B cell help (4).
Since the last 5 years, Tfh cells have been extensively studied 
in the lymph nodes (LNs) and spleens of individuals with chronic 
HIV/SIV infection. HIV infection is associated with an altered B 
cell differentiation (5) and Tfh isolated from LNs of HIV-infected 
(HIV+) individuals provide inadequate B cell help in vitro (6). As 
lymphoid tissue-resident Tfh cells are targeted by HIV/SIV early 
after infection, they constitute a major compartment for HIV 
infection, replication, and production of viral particles in LNs of 
viremic individuals (7–9), even though in vivo production of viral 
particles by Tfh cells remains to be demonstrated. Likewise, in 
blood, within central memory CD4T cells, cTfh cells serve as HIV 
reservoir in chronic HIV-infected individuals under antiretrovi-
ral therapy (10). Very recently, in natural HIV controllers, study 
of HIV infection in various CD4 T cell subsets demonstrates vari-
ous mechanism of HIV persistence according to the CD4 T cell 
compartment (11). LN-resident helper T cells (Tfh and non-Tfh) 
showed replicative virus, while clonally expanded blood CD4 
T cells harbor inducible provirus (11). However, despite their 
high susceptibility to HIV/SIV infection, many studies reported 
an accumulation of tissue-resident or cTfh populations during 
the chronic phases of infection (7, 8, 12, 13). In addition, Hong 
et al. demonstrate that after a rapid expansion of GCs during the 
acute phase, slowly proliferative Tfh cells accumulate during the 
chronic phase of SIV infection (14).
Various hypotheses can support the higher proportions of Tfh 
cell subsets in the context of chronic HIV infection: (i) Tfh cells 
might present high proliferative or survival capacities; (ii) antigen 
persistence could drive CD4 T cells toward Tfh differentiation; 
and (iii) regulatory cells that control the Tfh/B cell crosstalk 
might be defective.
Here, we propose to review recent studies based on transcrip-
tional analysis of Tfh cell subsets and to discuss the potential 
consequences on GC deregulations reported in chronic HIV/SIV 
infection.
POTeNTiAL iMPACT OF Hiv iNFeCTiON 
ON Tfh CeLL DiFFeReNTiATiON
The signals involved in Tfh cell differentiation include TCR 
activation, costimulation, cytokines, and migration-associated 
molecules. However, the origin of Tfh cells is not well defined 
in humans: it is not clear whether Tfh fate is established at the 
time of DC priming or later. Here, we review the impact of HIV 
infection on Tfh cell differentiation, from the priming of CD4 T 
cells by DCs cells until their ultimate stage of differentiation cor-
responding to GC Tfh and circulating memory Tfh. Two distinct 
differentiation pathways have been described (Figure 1).
The linear multistage Tfh differentiation pathway implicates 
multiple antigen-specific interactions in secondary lymphoid 
organs: (i) DC priming of naïve T cells leads to the rise of pTfh 
cells expressing CXCR5 molecule; pTfh cells migrate toward 
the T/B cell border zone where they experience (ii) a second 
antigen-specific interaction with B cells. This interaction leads 
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to the progression of pTfh cells within the B cell follicle and 
differentiation into Tfh cells. (iii) In the B cell follicle, Tfh cells 
experience multiple interactions with B cells, leading to B cell 
maturation and the complete differentiation of Tfh cells into GC 
Tfh. Thus in this model, B cells appear central in the terminal 
differentiation of Tfh cell into GC Tfh and reciprocally, Tfh are 
also required for B cell maturation. As with other helper T cell 
subsets, the stimulatory cytokines produced by DCs during the 
priming of naïve T cells are critical parameters of Tfh cell dif-
ferentiation. Using monocyte-derived DCs (MoDCs), Schmitt 
et al. demonstrated the key role of IL-12-producing MoDCs in the 
induction of IL-21-producing Tfh-like cells (15). More recently, 
the same group found that TGF-β acts together with IL-12 and 
IL-23 to induce the expression of various molecules associated 
with Tfh functions by human naïve helper T cells, including 
CXCR5, ICOS, IL-21, Bcl-6, and the transcription factors BATF 
and c-Maf (16). However, little is known about the type of DCs 
responsible for inducing Tfh cell priming. A recent study reported 
that engagement of DC-SIGN by fucose-based PAMPs licenses 
DCs for inducing Tfh polarization (17). Such activated DCs pro-
duce IL-27, which is essential for Tfh polarization. This finding 
highlights the importance of adjuvants in the induction of Tfh 
cells. Interestingly, HIV particles bind DC-SIGN through Gp120, 
the viral envelope (18). Therefore, one can hypothesize that, 
under chronic HIV infection, interactions between HIV particles 
and DC-SIGN expressing DCs could support the T helper cell 
differentiation toward a Tfh polarization. A recent study also 
showed that treatment with CpG (TLR-9 ligand) induces IL-6 
production by MoDC, orientating helper T cells differentiation 
toward the Tfh-cell lineage (19). Indeed, by inducing Bcl6 early 
during the T cell activation, IL-6 has been shown to be critic for 
Tfh polarization (20). In the context of HIV/SIV infection, several 
groups reported higher plasma levels of IL-6 (13, 21). However, 
we and others (22) did not find any difference in the amount 
of secreted IL-6 between HIV-infected and -uninfected spleens 
upon activation (8). Once engaged into Tfh differentiation, the 
sequential differentiation model proposes that pTfh/B cell inter-
actions dictate the fate of Tfh cells. Several groups highlighted the 
requirement of antigen presentation by B cells to induce Tfh cell 
and in turn GC reactions. In the absence of B cells, DC restricted 
antigen presentation initiates Tfh cell differentiation (into pTfh) 
but fails to complete ultimate effector Tfh cell differentiation 
(23). In a model of bone marrow chimera, B cells deficient for 
the expression of MHC-II-molecules exhibit a reduced capac-
ity to initiate T cell expansion and differentiation (24). In fact, 
sequential antigen-specific interactions of Tfh cell with DC and 
B cells are required to initiate Tfh cell and GC differentiation 
(25), and antigen persistence sustains Tfh responses and GC 
reactions (26). Using live multiphoton imaging, Schwickert et al. 
suggested that the amount of peptide–MHC (pMHC) complexes 
presented by antigen-specific B cells to cognate T cells, at the 
B-cell–T-cell border, was a limiting factor regulating the entry of 
B cell clones into GC (27). Furthermore, highlighting the critical 
role of MHC-II molecules expressed by B cells in the generation 
of Abs of diverse functions and of memory B-cell responses, B 
cells lacking MHC-II expression are unable to differentiate into 
memory cells and are defective in producing antigen-specific IgG 
(28). These results demonstrate that MHC-II-restricted antigen 
presentation by B cells is strictly required for B cells to receive 
help by antigen-specific Tfh cells, and thus to establish a potent 
humoral immune response. Therefore, Tfh cell differentiation 
and GC development require the combination of DC and B cell 
antigen presentation.
As DC during T cell priming, B cells also provide additional 
signals to Tfh cells, contributing to their helper functions and 
maintenance. These signals include CD40L/CD40, OX40/
OX40L, signaling lymphocyte activation molecule (SLAM) fam-
ily members, and adhesion molecules that strengthen GC Tfh/
GC B cell interaction. Interaction between ICOS and ICOS ligand 
(ICOSL) as well as IL-21 production has been implicated in GC 
formation (29, 30). PD-1/PD-1 ligand interactions also control 
Tfh and GC B cell differentiation (1, 31). Murine Tfh cells also 
express the nutrient transporter folate R 4 (FR4) and CD73 (32) 
although their functional relevance for Tfh cell differentiation 
and B cell help has not yet been uncovered. In sum, the sequential 
differentiation proposes that combined interactions with DC and 
B cell dictate the fate of Tfh cells.
The alternative “post effector” developmental pathway pro-
poses that Tfh-like cells may develop either from the memory 
CD4 T cell lineage (33, 34) or from effector T helper cell subsets 
(35, 36), rather than arising from pTfh cells. It has been shown 
that Tfh and central memory T cells (TCM) are similar in their 
developmental pathway, including the requirement of Bcl6 and 
low levels of IL-2 signaling (37). In line with this, Tfh and TCM 
gene programs can co-initiate from effector Th1 cells upon 
increased Bcl-6 expression in response to a decrease of IL-2, 
resulting in a “Tfh/TCM-like” population. IL-7 signaling also acts 
as a negative feedback that downregulates the differentiation 
of Th1 into Tfh-like cells (38). Interestingly, in spleens from 
HIV-infected individuals with a high proportion of Tfh cells, we 
reported a markedly reduced expression of the IL-7r encoding 
gene in all CD4 T cell populations (8). Taken together these 
observations support the hypothesis that, in addition to Tfh cells, 
other T helper populations may contribute to B cell maturation 
into long-lived plasma cells. Hence, in humans, the precursors of 
Tfh cells might be composed of heterogeneous cell populations, 
which have the ability to differentiate into distinct types of Tfh 
cells. The latter keep some functional imprint from the parental 
T cell subtype. Of note, in this alternative pathway, interactions 
with antigen-presenting B cells are still a key event of the Tfh cell 
orientation thus raising the question of the impact of Tfh infec-
tion by HIV on the B cell compartments.
Germinal center Tfh cells have long been considered as 
the terminal stage of tissue-resident Tfh cell differentiation. 
Newly identified, memory Tfh cells are preferentially located 
in secondary lymphoid organs and bone marrow although they 
can recirculate in the blood. These cTfh involve several subsets 
that differentially support Ab secretion (4) and are related to 
lymphoid-tissue-resident Tfh cells by their gene expression 
profile, cytokine production, and functional properties (39). 
Recently, adding to the CXCR5 and PD-1 canonical markers, 
Schultz et al. proposed that cTfh can be identified by their ability 
to produce IL-21, the cardinal Tfh cytokine (40). Interestingly, 
activated memory B cells induce rapid re-expression of Bcl6 by 
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memory Tfh cells (41), reinforcing the concept that many features 
of Tfh cells are highly linked with those of the B cells. Thanks to 
their accessibility and relative high frequencies, cTfh cell dynam-
ics and features are the focus of growing interest in the context of 
infection and vaccination.
THe FReQUeNCY AND FUNCTiONS OF 
Tfh CeLLS ARe TiGHTLY CONTROLLeD
Follicular helper T cell homeostasis is critical to the induction of 
high affinity Ab responses that are devoid of self-reactivity. Indeed, 
optimal Tfh cell frequency imposes competition between B cells, 
thus favoring survival of high affinity B cell clones. Several cell 
populations maintain Tfh cell homeostasis, including regulatory 
T (Treg) cells, Tfr cells, CD8 regulatory cells, and plasma cells (42). 
Tfr cells are identified as the main T cell subset implicated in the 
control of Tfh cells. They migrate into follicles and directly control 
GC reaction (43, 44). Hence, many studies have demonstrated 
increased GC and T cell responses in the absence of Tfr (43, 45, 
46). Tfr cells co-express Bcl6 and Blimp-1 (43) that is known to 
negatively regulate Tfh cell differentiation pathway (47). Indeed, 
Blimp-1 represses Bcl-6 and reciprocally, which might explain the 
lower expression of Bcl-6 in Tfr cells as compared to Tfh cells 
(43). Tfr cells express CTLA-4 and produce high amounts of 
IL-10. They have been shown to arise from Foxp3+ precursors 
that highjack the Tfh differentiation pathway. However, a recent 
study showed that, using an appropriate vaccine adjuvant, Tfr 
cells can derive directly from naïve CD4 T cells (48). Alteration 
of Tfr cells functionality might contribute to higher proportions 
of Tfh cells during HIV-infection. Our results indicated that HIV 
infection did not impact splenic Tfh/Tfr ratio suggesting that Tfr 
and Tfh cell subsets expended equally during HIV infection (8). 
However, Chowdhury et al. have shown a limited expansion of 
Tfr cells as compared to the one of Tfh cells during SIV infec-
tion (49). They explored the transcriptional profile of CXCR5+ 
PD1hiCD127-CD25+ Tfr cells after SIV infection. Overall, 
genes linked with Tfh differentiation and functions, such as 
PD-1, IL-6R, SLAMF6, and CD84, were more expressed in Tfr 
cells, while expression of IL-2RA linked with Treg functions was 
reduced after SIV infection suggesting that SIV infection might 
impair expression of genes associated with Treg and thus Tfr 
regulatory functions (49).
According to their transcription profile, Tfr cells are situated 
between Tfh and Treg cell subsets. However, foxp-3 expression 
is not taken into account in most Tfh cell studies that de facto 
include Tfr subset among Tfh cells. Recently, adding to Tfr cells, 
Treg cells expressing CTLA-4 have been reported as major inhibi-
tors of B cell expression of CD80 and CD86, which are essential 
to the induction of Tfh cells (50–52).
Tfh CeLL DYNAMiCS DURiNG THe 
COURSe OF Hiv/Siv iNFeCTiON
Follicular helper T and cTfh cells are targeted by HIV/SIV very 
early after infection and constitute a major compartment for HIV 
replication and production of viral particles in LNs and periphery 
of viremic individuals (7–9, 11). Despite their high susceptibility 
to HIV/SIV infection, most studies reported an accumulation of 
tissue-resident or cTfh cell populations (7, 8, 12, 13). Interestingly, 
the Tfh cell frequency positively correlates with plasma viremia 
levels (7, 12), and Tfh cell accumulation is reduced in individuals 
that control SIV infection (53), suggesting that the persistence of 
viral antigens might drive Tfh cell expansion. Accordingly, cTfh 
cell expansion has been recently reported in untreated individu-
als while the frequency of cTfh cells is restored to normal levels 
under cART suggesting that HIV replication also drives cTfh cell 
dynamics (10). Most studies report an increase of Tfh cells among 
memory CD4 T cells during HIV/SIV infection, whereas others 
conclude with the opposite statement (9, 54). In SIV-infected rhe-
sus macaques, Moukambi et al. recently showed that Tfh dynam-
ics differs from one compartment to another (peripheral blood 
vs. LNs or spleen) (9). Moreover, the Tfh cell frequency varies 
according to (i) the stage of HIV/SIV infection (53), (ii) the sever-
ity of the disease, and (iii) the ability to develop broadly neutral-
izing antibodies (bNAbs) (39, 55). In Table 1, we summarized Tfh 
cell dynamics from various studies taking into account: the type 
of infection (HIV/SIV), the phase (acute vs. chronic), the disease 
progression (slow vs. fast), the immune compartment (peripheral 
blood vs. secondary lymphoid organs), the phenotype, and the 
antigen specificity of the Tfh cells. Irrespective of the immune 
compartment (LNs, spleen, or blood), Tfh cells are preserved in 
HIV/SIV controllers, displaying no Tfh cell accumulation or loss. 
On the contrary, Tfh cell loss is reported in fast progressors as well 
as in the late stages of disease.
Follicular helper T cell accumulation is reported during 
slow progression (SP) or chronic stage of the disease. Indeed, 
evidences support the pivotal role of persistent viral antigen 
within the GC in driving Tfh cell expansion. HIV particles are 
associated with FDC in tonsils and LNs from infected patients 
(58–60) and Cheynier et al. reported the persistence of high levels 
of HIV particles in GC of HIV+ spleens from untreated subjects 
(61). In addition to FDC-bound virions, opsonized HIV particles 
interact with B cells trough CD21 membrane receptor (62, 63). 
Remarkably, the accessibility of CTL to GC is reduced, thus limit-
ing the elimination of HIV-infected cells (64). Therefore, B cell 
follicles locally concentrate cell subsets implicated in HIV repli-
cation and viral production, which maintain antigen persistence 
and GC reactions. It appears that antigen persistence sustains 
ongoing GC reactions in which Tfh and GC B cell frequencies are 
highly correlated (8, 12, 65). However, a limited number of fully 
functional Tfh cells is required for the induction of bNAbs (42).
Another clue supporting the pivotal role of GC in driving Tfh 
cell expansion is that the disruption of GC organization coincides 
with the loss of Tfh cells and the onset of AIDS in terminal stages 
of SIV infection (53). PD1/PD-L2 axis contributes to the survival 
of Tfh and B cells. Interestingly, the expression of PD-L2 on B cells 
is severely impacted in the late stages of SIV infection potentially 
contributing to a decreased survival of T and B cells and the 
termination of GC reaction (53).
In sum, increased proportions of Tfh cells do not necessarily 
results in a better immune control of HIV infection, and Tfh cell 
proportions must be tightly regulated to allow efficient matura-
tion and selection of B cells displaying high B cell receptor (BCR) 
TAbLe 1 | Tfh cell dynamics in Hiv/Siv infection according to the stage (acute, chronic, or late) and the outcome of the disease.
Phase Disease outcome Compartment Phenotype Antigen specificity Dynamics Reference
SIV Acute P Spleen CXCR5+PD-1+ Total Loss (9)
SIV Acute Slow P LN CXCR5+PD-1+ Total Accumulation (14)
SIV Acute Fast P LN CXCR5+PD-1+ Total No Accumulation (14)
SIV Chronic Slow P LN CXCR5+PD-1+ Total Accumulation (56)
SIV Chronic Slow P Spleen, LN CD45RA-CD62L+CXCR5+PD-1+ Total Accumulation (9)
SIV Chronic Fast P LN CXCR5+PD-1+ Total Loss (9)
SIV Late P LN CXCR5+PD-1+ Total Loss (53)
SIV Chronic C LN CXCR5+PD-1+ Total Preservation (53)
SIV Chronic P LN CXCR5+PD-1+ Total Accumulation (57)
SIV Chronic ND LN CD28hiCD95hi CCR7loPD-1hi Total Accumulation (13)
HIV Acute C Blood CXCR5+PD-1+ Total Preservation (55)
HIV Chronic P Blood CCR7+CXCR5+CCR6+PD-1+(±CXCR3) Total Loss (54)
HIV Chronic High neutralizers Blood CCR7lowCXCR5+PD-1+CXCR3- Total Preservation (39)
HIV Chronic ND Blood CCR7+CXCR5+PD-1+CXCR3− Total Accumulation (10)
HIV Chronic ND LN CXCR5+PD-1+Bcl-6+ HIV-specific Accumulation (7)
HIV Chronic ND LN CXCR5+PD-1+Bcl-6+(CCR7−CD45RA−) Total/HIV-specific Accumulation (12)
HIV Chronic ND Spleen CCR7-CD45RA-CXCR5+PD-1+ Total Accumulation (8)
P, progressors; C, controllers; ND, non-determined.
The phenotype and the immune compartment [spleen, blood, or lymph nodes (LNs)] are mentioned.
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affinity. Tfh cell functions need to be preserved to allow the 
production of potent bNAbs.
ALTeRATiON OF Tfh CeLL FUNCTiONS iN 
THe CONTeXT OF Hiv iNFeCTiON
The key role of Tfh cells is to provide B cell helper signals and 
to promote their differentiation into memory B cell displaying 
high affinity for pathogens. These signals consist of production 
of cytokines, such as IL-4 and IL-21, and the expression of cell 
surface molecules, such as OX40, ICOS, and CD40L, by Tfh cells 
(1). As other groups, we analyzed the transcriptome profiles of 
Tfh as a mean to assess potential Tfh dysfunctions (see references 
in Table 2). Using single-cell sorting and high-throughput PCR 
(Fluidigm BioMark HD), we showed that expression of genes 
implicated in splenic Tfh and GC Tfh cell functions are deeply 
impacted by chronic HIV infection (8). In this section, we intend 
to review the impact of HIV/SIV infection on the main signals 
implicated in Tfh cell functions.
CD40L–CD40 (expressed by Tfh and B cell, respectively) 
interactions are required for the induction and maintenance of 
GC reaction. Blocking this molecular axis leads to GC disruption 
(67). In line with this, mutation in the CD40L gene is responsible 
for the X-linked hyper-IgM syndrome in humans characterized 
by a markedly decreased serum concentrations of IgA, IgE, and 
IgG (68). Our transcriptional data showed that the expression of 
CD40L gene is severely impacted in Tfh and GC Tfh from HIV-
infected spleens (8). Of note, CD40L down modulation has been 
reported in global CD4+ T cell population during the late stages 
of HIV infection (69) and our unpublished data.
OX40–OX40L interaction is required for B cell differentiation 
into plasma cells (70). In humans, mutations in OX40 gene lead 
to decreased proportion of circulating memory B cells but do 
not impact the Ab responses (71). HIV-infected spleens exhibit 
defective expression of gene encoding OX40 in Tfh and GC Tfh 
cells (8). Intriguingly, we reported a reduction of memory B cell 
compartment in chronically HIV-infected individuals. Whether 
OX40 defective expression by Tfh is involved in this decrease in 
memory B cell should be further investigated.
During GC reactions, the expression ICOS by Tfh cells plays a 
major role in the process of selection of high affinity B cells. ICOS 
ligation leads to the overexpression of CD40L by Tfh cells that, 
in turn, promote the expression of ICOSL by GC B cells (72). In 
mice, recent findings emphasize the crucial role of T and B cell 
interactions through ICOS–ICOSL and CD40L–CD40 molecular 
axis in the maintenance of GC reactions and the production of 
high affinity bone-marrow plasma cells. ICOSL has been iden-
tified as a key regulator of positive selection of high affinity B 
cells during T–B cell interaction. Noteworthy, in comparison 
with uninfected donors, ICOS expression is enhanced in cTfh of 
ART-treated HIV-infected individuals (54) suggesting an overall 
immune activation of cTfh in those patients.
IL-21 is considered as the cardinal cytokine of the Tfh cell 
population. Tfh-secreted IL-21 induces B cell affinity maturation 
(73). A defective production of IL-21 by Tfh cells as well as a 
defective expression of its receptor by B cells severely impacts B 
cell proliferation and their differentiation into plasma cells (74). In 
the context of HIV infection, circulating CD4+ T cells secreting 
IL-21 are defined as the closest relative of tissue-resident (from 
secondary lymphoid organs) Tfh cells, both phenotypically and 
transcriptionally (40). cTfh cells from chronically HIV-infected 
individuals present altered expression of IL-21 gene (54) suggest-
ing defective helper function. Conversely, we showed higher level 
of IL-21 transcripts in Tfh cells from chronically HIV-infected 
spleens (8) while Moukambi et  al. reported a similar level of 
expression between Tfh from uninfected macaques and SIV-
infected macaques during the early and the chronic phases of SIV 
infection (9). Discrepancies concerning the stage of the disease 
as well as the immune compartment (blood, spleen, and LNs) 
might explain these conflicting observations. Higher levels of 
IL-21 transcripts in cTfh cells are associated with HIV-controller 
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status (66) or with cross-reactive neutralizing responses in rhesus 
macaques during the chronic phase of SIV infection (34–50 weeks 
post infection) (65).
IL-4 plays a major role in Tfh function (1) and confers anti-
apoptotic properties to GC B cells that are particularly susceptible 
to cell death by apoptosis (75). IL-4 also participates to GC B 
cells selection (76). Tfh cells from SIV-infected rhesus macaques 
showed a marked reduction of IL-4 gene expression, and a global 
alteration of genes implicated in the network associated with IL-4 
pathway (13). A defective expression of IL-4 gene has also been 
reported in cTfh from ART-treated HIV-infected individuals 
(54). We have shown a decreased secretion of IL-4 and IL-10 in 
splenocytes from chronically HIV-infected individuals (8). IL-10 
contributes to B cell differentiation (77). Altered IL-10 secretion 
was also confirmed at the transcriptional level (8). However, our 
experimental settings did not allow the discrimination of Tfh cells 
from the Tfr subset and IL-10 deficiencies might also be related 
to defective Tfr functions.
SLAMF1 is specifically required for IL-4 and IL-21 produc-
tion by GC Tfh cells (78), and SAP (SLAM-associated protein) is 
essential for GC reaction by stabilizing interaction between Tfh 
and B cells (79). In spleens from HIV-infected donors, we also 
observed a defective SLAMF1 gene expression in Tfh cell subsets 
that might explain the low level of IL-4 production by splenocytes 
from HIV-infected patients (8).
Altogether, these results indicate that HIV infection severely 
impacts Tfh cell functions in their capacity to provide adequate 
B cell help. These alterations result from both intrinsic Tfh cell 
defects and higher proportions of Tfh cells. Whether HIV infec-
tion alters Tfr cell functions is not clear. This issue will require 
further studies, especially addressing the capacities of Tfr cells 
to suppress Tfh cell functions or differentiation as well as B cell 
maturation. However, it will require identifying Tfr specific 
extracellular markers.
ReQUiReMeNT FOR eARLY ART 
iNiTiATiON AND OPTiMiZeD 
ACCeSSibiLiTY TO LYMPHOiD TiSSUeS
HIV/SIV infection results in antigen persistence that drives CD4 
T cell differentiation toward the Tfh phenotype, thus maintaining 
high level of Tfh cells in GC. By controlling viremia, introduction 
of cART allows a normalization of cTfh cell proportions while 
Tfh cell functions are not fully restored. In particular, in  vitro 
production of immunoglobulin is reduced in both untreated 
patients and HIV-infected individuals under cART (54). Hence, 
despite cART, HIV patients showing a detectable viral load 
(163 ± 178 HIV RNA copies/mL) did not respond to the 2009 
H1N1/09 vaccine, whereas vaccine responders displayed unde-
tectable viral loads (<40 HIV RNA copies/mL). This suggests that 
the persistence of viremia compromises Tfh cell functions (80). 
Altogether, early control of viremia appears crucial to preserve 
Tfh cells functions. Additionally, while B cell compartment is not 
recovered in chronically infected individuals under cART, early 
cART initiation restores the memory B cell compartment during 
acute HIV infection (81).
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Early cART initiation during primo infection allows a dramatic 
decrease of cell-associated HIV DNA and thus limits establish-
ment of the reservoir (82, 83). However, the poor penetration of 
cART into lymphoid tissues (84) could limit the efficiency of drugs 
even if cART was initiated early. To address these limitations, 
several approaches, mainly based on the molecular formulation 
of drugs, are actually envisaged. Injectable cART could overcome 
the limited access to lymphoid tissues. In the LATTE clinical trial, 
injection of combined cabotegravir and rilpivirine was well toler-
ated and efficient (85). However, the relevance of this approach 
on the persistence of the HIV reservoir has not been reported yet. 
Very recently, the efficient elimination of latently HIV-infected 
cells using HIV protease-sensitive toxin nanocapsules has been 
reported (86). This strategy presents the advantage to specifically 
eliminate HIV-infected cells without impacting healthy cells, 
allowing a less invasive approach. Combining new ART formula-
tions with innovative route of administration could contribute to 
eradicate HIV reservoir from lymphoid organs.
In conclusion, HIV/SIV infections target Tfh cell subsets and 
severely affect Tfh cell frequency and functions, with dramatic 
impact on GC homeostasis. While limited number of fully func-
tional Tfh cells is required for the induction of bNAbs, it is now 
well established that viral antigen persistence drives increased 
Tfh cell differentiation. To this regard, blocking HIV replication 
in lymphoid tissues might be a prerequisite to the induction of 
potent bNAbs. Preventing virus from entering lymphoid tissues 
should give another benefit to early ART initiation as well as the 
development of new strategies to optimize the access of ART to 
lymphoid tissues.
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